Within the Cataract Surgery Devices Market , phacoemulsification equipment holds the largest share, reflecting its status as the standard of care for cataract surgery. Phacoemulsification uses ultrasonic energy to break up the cloudy lens (cataract) into small pieces, which are then aspirated from the eye through a small incision. This technique has largely replaced manual extracapsular cataract extraction (ECCE) due to its advantages of smaller incisions, faster recovery, and reduced complications. The phacoemulsification segment includes the phacoemulsification machine, handpieces, tips, and associated consumables such as tubing and cassettes.

While phacoemulsification equipment leads, femtosecond laser-assisted cataract surgery (FLACS) systems are the fastest-growing segment. FLACS uses a femtosecond laser to perform several key steps of the cataract surgery procedure, including creating the corneal incisions, performing the capsulotomy, and fragmenting the lens. FLACS offers potential advantages over traditional phacoemulsification, including greater precision, reproducibility, and reduced phacoemulsification energy, which may lead to better outcomes. However, FLACS systems are expensive, which has limited their widespread adoption. As technology advances and costs decrease, FLACS is expected to capture an increasing share of the market.

Intraocular lenses (IOLs) are another critical segment of the market. IOLs are implanted in the eye to replace the natural lens after it is removed. The market offers a wide range of IOLs, from monofocal IOLs that provide good distance vision to premium IOLs that correct presbyopia (multifocal and EDOF IOLs) and astigmatism (toric IOLs). The demand for premium IOLs is growing as patients seek to reduce their dependence on glasses after surgery.

Other devices used in cataract surgery include viscoelastic devices, which maintain the shape of the eye during surgery, and surgical microscopes, which provide magnification and illumination.

The growth of the phacoemulsification segment is driven by the high volume of cataract surgeries performed globally. The growth of FLACS is driven by the desire for greater precision and improved outcomes, particularly in patients with complex cataracts or premium IOL implants.